Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Corium International, Inc. (NASDAQ: CORI).

Full DD Report for CORI

You must become a subscriber to view this report.


Recent News from (NASDAQ: CORI)

Corium International's (CORI) CEO Peter Staple on Q2 2018 Results - Earnings Call Transcript
Corium International, Inc. (CORI) Q2 2018 Results Earnings Conference Call May 14, 2018, 5:00 pm ET Executives Robert Breuil - Chief Financial Officer Peter Staple - President, Chief Executive Officer Analysts Oren Livnat - H.C. Wainwright Serge Belanger - Needham Presen...
Source: SeekingAlpha
Date: May, 14 2018 20:10
Corium misses by $0.11, beats on revenue
Corium (NASDAQ: CORI ): Q2 EPS of -$0.50 misses by $0.11 . More news on: Corium International, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 14 2018 16:13
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the se...
Source: GlobeNewswire
Date: May, 14 2018 16:01
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 after the close of the U.S. financial markets.  Corium will host ...
Source: GlobeNewswire
Date: May, 08 2018 08:00
Corium to Present at the 17th Annual Needham Healthcare Conference
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Coriumȁ...
Source: GlobeNewswire
Date: March, 19 2018 08:00
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the pricing of its offering of $100,...
Source: GlobeNewswire
Date: March, 01 2018 08:35
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
MENLO PARK, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it intends to offer, subject to ...
Source: GlobeNewswire
Date: February, 28 2018 16:15
Corium International: Will This Stellar Growth Company Continue To Deliver Profits?
If the job has been correctly done when a common stock is purchased, the time to sell it is – almost never. - The Father of Growth Investing (Philip Fisher) In the past 52-weeks, the shares of Corium International (NASDAQ: CORI ) - a specialty bioscience that focuses on the inno...
Source: SeekingAlpha
Date: February, 21 2018 03:22
Corium (CORI) Presents At BIO CEO & Investor Conference - Slideshow
The following slide deck was published by Corium International, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: February, 13 2018 14:14
Corium International's (CORI) CEO Peter Staple on Q1 2018 Results - Earnings Call Transcript
Corium International, Inc. (CORI) Q1 2018 Earnings Conference Call February 08, 2018, 17:00 ET Executives Robert Breuil - CFO Peter Staple - President, CEO & Director Analysts Oren Livnat - H.C. Wainwright & Co. William Tanner - Cantor Fitzgerald & Co. Stephen...
Source: SeekingAlpha
Date: February, 08 2018 21:14

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-189.509.179.67259.13259,474
2018-05-179.509.179.67259.13259,474
2017-12-1311.1611.46511.8810.90176,701
2017-12-1211.2111.1511.3110.82170,348
2017-12-1111.2711.1511.5010.7955185,468

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2238,657133,61528.9316Cover
2018-05-2179,347112,07770.7969Short
2018-05-1867,703160,48142.1875Short
2018-05-1739,80078,08850.9681Short
2018-05-1627,59479,88734.5413Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CORI.


About Corium International, Inc. (NASDAQ: CORI)

Logo for Corium International, Inc. (NASDAQ: CORI)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: CORI)

      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 15 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 20 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 16 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: March, 15 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: March, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 01 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: February, 28 2018

       

       


      Daily Technical Chart for (NASDAQ: CORI)

      Daily Technical Chart for (NASDAQ: CORI)


      Stay tuned for daily updates and more on (NASDAQ: CORI)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: CORI)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      The Subway Trader
      @TheSubwayTrader

       

       


      Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CORI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of CORI and does not buy, sell, or trade any shares of CORI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/